AIG
CHRS icon

American International Group’s Coherus Oncology CHRS Stock Holding History

American International Group’s Portfolio CHRS Stock Details CHRS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-51,732
Closed -$124K – 530
2024
Q1 		$124K Buy
51,732
+2,123
+4% +$5.22K ﹤0.01% 2401
2023
Q4 		$165K Sell
49,609
-200
-0.4% -$536 ﹤0.01% 2273
2023
Q3 		$186K Buy
49,809
+9,053
+22% +$41.8K ﹤0.01% 2168
2023
Q2 		$174K Buy
40,756
+1,123
+3% +$6.63K ﹤0.01% 2257
2023
Q1 		$271K Buy
39,633
+243
+0.6% +$1.89K ﹤0.01% 1947
2022
Q4 		$312K Sell
39,390
-287
-0.7% -$2.21K ﹤0.01% 1866
2022
Q3 		$381K Buy
39,677
+465
+1% +$4.71K ﹤0.01% 1745
2022
Q2 		$284K Buy
39,212
+2,067
+6% +$18K ﹤0.01% 1946
2022
Q1 		$480K Sell
37,145
-2,286
-6% -$29.1K ﹤0.01% 1745
2021
Q4 		$629K Sell
39,431
-767
-2% -$13.4K ﹤0.01% 1673
2021
Q3 		$646K Sell
40,198
-1,673
-4% -$24.5K ﹤0.01% 1690
2021
Q2 		$579 Sell
41,871
-26,025
-38% -$369K ﹤0.01% 1824
2021
Q1 		$992 Sell
67,896
-4,184
-6% -$71K ﹤0.01% 1461
2020
Q4 		$1.25K Buy
72,080
+31,651
+78% +$564K ﹤0.01% 1281
2020
Q3 		$742K Sell
40,429
-818
-2% -$15.2K ﹤0.01% 1394
2020
Q2 		$737K Buy
41,247
+4,204
+11% +$71.2K ﹤0.01% 1385
2020
Q1 		$601K Sell
37,043
-2,141
-5% -$39.6K ﹤0.01% 1340
2019
Q4 		$706K Buy
39,184
+100
+0.3% +$1.84K ﹤0.01% 1510
2019
Q3 		$792K Sell
39,084
-273
-0.7% -$5.46K ﹤0.01% 1416
2019
Q2 		$870K Buy
39,357
+6,254
+19% +$109K ﹤0.01% 1394
2019
Q1 		$452K Sell
33,103
-1,072
-3% -$14.3K ﹤0.01% 1769
2018
Q4 		$309K Sell
34,175
-263
-0.8% -$3.04K ﹤0.01% 1931
2018
Q3 		$568K Buy
34,438
+3,941
+13% +$69.9K ﹤0.01% 1810
2018
Q2 		$427K Buy
30,497
+5,176
+20% +$74.1K ﹤0.01% 1940
2018
Q1 		$280K Sell
25,321
-517
-2% -$5.66K ﹤0.01% 2071
2017
Q4 		$227K Buy
25,838
+123
+0.5% +$1.32K ﹤0.01% 2248
2017
Q3 		$343K Buy
25,715
+1,922
+8% +$25.4K ﹤0.01% 1979
2017
Q2 		$341K Buy
23,793
+3,280
+16% +$63.1K ﹤0.01% 1950
2017
Q1 		$434K Buy
20,513
+3,554
+21% +$87.4K ﹤0.01% 1686
2016
Q4 		$477K Sell
16,959
-44
-0.3% -$1.23K ﹤0.01% 1667
2016
Q3 		$455K Buy
17,003
+26
+0.2% +$709 ﹤0.01% 1669
2016
Q2 		$287K Buy
16,977
+3,166
+23% +$59.4K ﹤0.01% 1903
2016
Q1 		$293K Hold
13,811
– – ﹤0.01% 2431
2015
Q4 		$317K Sell
13,811
-24
-0.2% -$618 ﹤0.01% 2392
2015
Q3 		$277K Buy
13,835
+16
+0.1% +$487 ﹤0.01% 2520
2015
Q2 		$399K Buy
13,819
+9,541
+223% +$241K ﹤0.01% 2375
2015
Q1 		$131K Hold
4,278
– – ﹤0.01% 3351
2014
Q4 		$69.8K Buy
+4,278
New +$60.4K ﹤0.01% 3810

Other funds holding CHRS

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
RCMNY
Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return
Temasek Holdings
Temasek Holdings Singapore $30.5B AUM 13.98% 1-Year Est. Return
KKRC
Kohlberg Kravis Roberts & Co New York $5.35B AUM 63.01% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Barclays
Barclays London, United Kingdom $416B AUM 33.63% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

American International Group's CHRS Position: Q2 2024 in Review

American International Group sold out of Coherus Oncology (CHRS) in Q2 2024, closing a stake of 51,732 shares — an estimated $124K sold.

American International Group first reported a position in CHRS in Q4 2014 and held it in 38 quarters. The position peaked at $870K in Q2 2019. 135 funds tracked by Wall St. Rank hold CHRS as of Q2 2024.

  • American International Group reported no remaining Coherus Oncology position as of Q2 2024 after selling out during the quarter.
  • American International Group sold 51,732 Coherus Oncology shares in Q2 2024, an estimated $124K.
  • American International Group first reported a position in Coherus Oncology in Q4 2014 and held it in 38 quarters.
  • American International Group's Coherus Oncology position peaked at $870K in Q2 2019.
  • 135 funds tracked by Wall St. Rank held Coherus Oncology as of Q2 2024.

Based on American International Group's 13F filing for Q2 2024, filed 13 Aug 2024.